SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD
For best results when printing this announcement, please click on link below: SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD Milestone follows nearly US$7 million in seed investment and strategic support from SOLVE FSHD SOLVE FSHD, a venture-philanthropy